Immunoproteomic analysis of Bordetella pertussis and identification of new immunogenic proteins

Vaccine

Volumn 27, Issue 4, 2009, Pages 542-548

  Altindiş, Emrah ^a   Tefon, Burcu E ^a   Yildirim, Volkan ^a   Özcengiz, Erkan ^b   Becher, Dörte ^c   Hecker, Michael ^c   Özcengiz, Gülay ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b Vaccine Biologicals Research Company   (Turkey)

^c UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Bordetella pertussis; Immunoproteomics; Vaccine candidates

Indexed keywords

EPITOPE;

ANIMAL EXPERIMENT; ANTIGEN DETECTION; ARTICLE; BORDETELLA PERTUSSIS; GENE LOCUS; IMMUNOGENICITY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BORDETELLA PERTUSSIS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; PROTEIN SORTING SIGNALS; PROTEOME; PROTEOMICS;

EID: 57749194604     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.11.020     Document Type: Article

References (62)

1. Locht C., Antoine R., and Jacob-Dubuisson F. Bordetella pertussis, molecular pathogenesis under multiple aspects. Curr Opin Microbiol 4 (2001) 82-89
2. Crowcroft N.S., and Britto J. Whooping cough-a continuing problem. BMJ 324 (2002) 1537-1538
3. Khan A.S., Mujer C.V., Alefantis T.G., Connolly J.P., Mayr U.B., Walcher P., et al. Proteomics and bioinformatics strategies to design countermeasures against infectious treat agents. J Chem Inf Model 46 1 (2006) 111-115
4. Serruto D., and Rappuoli R. Post-genomic vaccine development. FEBS Lett 580 (2006) 2985-2992
5. Nilsson C.L., Larsson T., Gustafsson E., Karlsson K., and Davidson P. Identification of protein vaccine candidates from Helicobacter pylori using a preparative two-dimensional electrophoretic procedure and mass spectrometry. Anal Chem 72 (2000) 2148-2153
6. Backert S., Kwok T., Schmid M., Selbach M., Moese S., Peek R., et al. Subproteomes of soluble and structure-bound Helicobacter pylori proteins analyzed by two dimensional gel electrophoresis and mass spectrometry. Proteomics 5 (2005) 1331-1345
7. Vytvytska O., Nagy E., Bluggel M., Meyer H.E., Kurzbauer R., Huber L.A., et al. Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis. Proteomics 2 (2002) 580-590
8. Ariel N., Zvi A., Makarava K.S., Chitlaru T., Elhanany E., Velan B., et al. Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens. Infect Immun 71 (2003) 4563-4579
9. Peng X., Ye X., and Wang S. Identification of novel immunogenic proteins of Shigella flexneri 2a by proteomic methodologies. Vaccine 22 21-22 (2004) 2750-2756
10. Havlasová J., Hernychová L., Halada P., Pellantová V., Krejsek J., Stulík J., et al. Mapping of immunoreactive antigens of Francisella tularensis live vaccine strain. Proteomics 2 7 (2002) 857-867
11. Hansmeier N., Chao T., Kalinowski J., Pühler A., and Tauch A. Mapping and comprehensive analysis of the extracellular and cell surface proteome of the human pathogen Corynebacterium diphtheriae. Proteomics 6 (2006) 2465-2476
12. Rodríguez-Ortega M.J., Norais N., Bensi G., Liberatori S., Capo S., Mora M., et al. Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome. Nat Biotechnol 24 2 (2006) 191-197
13. Bunk S., Susnea I., Rupp J., Summersgill J.T., Maass M., Stegmann W., et al. Immunoproteomic identification and serological responses to novel Chlamydia pneumoniae antigens that are associated with persistent C. pneumoniae infections. J Immunol 180 8 (2008) 5490-5498
14. LinksHsu C.A., Lin W.R., Li J.C., Liu Y.L., Tseng Y.T., Chang C.M., et al. Immunoproteomic identification of the hypothetical protein NMB1468 as a novel lipoprotein ubiquitous in Neisseria meningitidis with vaccine potential. Proteomics 8 10 (2008) 2115-2125
15. Parkhill J., Sebaihia M., Preston A., Murphy L.D., Thomson N., Harris D.E., et al. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 35 (2003) 32-40
16. Vidakovics M.L., Paba J., Lamberti Y., Ricart C.A., Sousa M.V., and Rodriguez M.E. Profiling the Bordetella pertussis Proteome during Iron Starvation. J Proteome Res 6 7 (2007) 2518-2528
17. Bottero D., Gaillard M.E., Fingermann M., Weltman G., Fernández J., Sisti F., et al. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains. Clin Vaccine Immunol 14 11 (2007) 1490-1498
18. Sato Y., and Arai H. Leucocytosis promoting factor of Bordetella pertussis. Infect Immun 6 (1972) 899-904
19. Ramagli L.S., and Rodrigez L.V. Quantitation of microgram amounts of protein in two-dimensional polyacrylamide gel electrophoresis sample buffer. Electrophoresis 6 (1985) 559-563
20. Gorg A., Weiss W., and Dunn M.J. Current two-dimensional electrophoresis technology for proteomics. Proteomics 4 (2004) 3665-3685
21. Neuhoff V., Arold N., Taube D., and Ehrhardt W. Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 9 (1988) 255-262
22. Saha S., and Raghava G.P. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins 65 1 (2006) 40-48
23. Gardy J.L., Laird M.R., Chen F., Rey S., Walsh C.J., Ester M., et al. PSORTb v.2. 0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics 21 5 (2005) 617-623
24. Mattoo S., and Cherry J.D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18 2 (2005) 326-382
25. Del Giudice G., Gervaix A., Costantino P., Wyler C.A., Tougne C., de Graeff-Meeder E.R., et al. Priming to heat shock proteins in infants vaccinated against pertussis. J Immunol 150 (1993) 2025-2032
26. Barnes P.N., Mehra V., Hirschfield C.R., et al. Characterisation of T cell antigens associated with the cell wall protein-peptidoglycan complex of Mycobucterium tuberculosis. J Immunol 143 (1989) 2656-2662
27. Ragno S., Winrow V.R., Mascagni P., Lucietto P., Di Pierro F., Morris C.J., et al. A synthetic 10-kD heat shock protein (hsp10) from Mycobacterium tuberculosis modulates adjuvant arthritis. Clin Exp Immunol 103 3 (1996) 384-390
28. Mehra V., Bloom B.R., Bajardi A.C., Grisso C.L., Sieling P.A., Alland D., et al. A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein. J Exp Med 175 1 (1992) 275-284
29. Chua-Intra B., Peerapakorn S., Davey N., Jurcevic S., Busson M., Vordermeier H.M., et al. T-cell recognition of mycobacterial GroES peptides in Thai leprosy patients and contacts. Infect Immun 66 10 (1998) 4903-4909
30. Pérez-Pérez G.I., Thiberge J.M., Labigne A., and Blaser M.J. Relationship of immune response to heat-shock protein A and characteristics of Helicobacter pylori-infected patients. J Infect Dis 174 5 (1996) 1046-1050
31. Wu Y.L., Lee L.H., Rollins D.M., and Ching W.M. Heat shock- and alkaline pH-induced proteins of Campylobacter jejuni: characterization and immunological properties. Infect Immun 62 10 (1994) 4256-4260
32. Adams E., Britton W.J., Morgan A., Goodsall A.L., and Basten A. Identification of human T cell epitopes in the Mycobacterium leprae heat shock protein 70-kD antigen. Clin Exp Immunol 94 3 (1993) 500-506
33. Kakeya H., Udono H., Maesaki S., Sasaki E., Kawamura S., Hossain M.A., et al. Heat shock protein 70 (hsp70) as a major target of the antibody response in patients with pulmonary cryptococcosis. Clin Exp Immunol 115 3 (1999) 485-490
34. Zysk G., Bongaerts R.J., ten Thoren E., Bethe G., Hakenbeck R., and Heinz H.P. Detection of 23 immunogenic pneumococcal proteins using convalescent-phase serum. Infect Immun 68 June (6) (2000) 3740-3743
35. Cohn M.T., Ingmer H., Mulholland F., Jørgensen K., Wells J.M., and Brøndsted L. Contribution of conserved ATP-dependent proteases of Campylobacter jejuni to stress tolerance and virulence. Appl Environ Microbiol 73 24 (2007) 7803-7813
36. Wang C., Li M., Dong D., Wang J., Ren J., Otto M., et al. Role of ClpP in biofilm formation and virulence of Staphylococcus epidermidis. Microbes Infect 9 11 (2007) 1376-1383
37. Michel A., Agerer F., Hauck C.R., Herrmann M., Ullrich J., Hacker J., et al. Global regulatory impact of ClpP protease of Staphylococcus aureus on regulons involved in virulence, oxidative stress response, autolysis, and DNA repair. J Bacteriol 188 16 (2006) 5783-5796
38. Movahedi A., and Hampson D.J. Distribution of the clpX gene in Brachyspira species and reactivity of recombinant Brachyspira pilosicoli ClpX with sera from mice and humans. J Med Microbiol 56 Pt 7 (2007) 930-936
39. Sakolvaree Y., Maneewatch S., Jiemsup S., Klaysing B., Tongtawe P., Srimanote P., et al. Proteome and immunome of pathogenic Leptospira spp. revealed by 2DE and 2DE-immunoblotting with immune serum. Asian Pac J Allergy Immunol 25 1 (2007) 53-73
40. Stübs D., Fuchs T.M., Schneider B., Bosserhoff A., and Gross R. Identification and regulation of cold-inducible factors of Bordetella bronchiseptica. Microbiology 151 (2005) 1895-1909
41. Fernández-Arenas E., Gloria M., César N., Rosalía D.O., and Concha G. Low virulent strains of Candida albicans: unravelling the antigens for a future vaccine. Proteomics 4 (2004) 3007-3020
42. Ehrmann M., and Clausen T. Proteolysis as a regulatory mechanism. Annu Rev Genet 38 (2004) 709-724
43. Sanchez-Campillo M., Bini L., Comanducci M., Raggiaschi R., Marzocchi B., Pallini V., et al. Identification of immunoreactive proteins of Chlamydia trachomatis by Western blot analysis of a two-dimensional electrophoresis map with patient sera. Electrophoresis 20 11 (1999) 2269-2279
44. Bumann D., Holland P., Siejak F., Koesling J., Sabarth N., Lamer S., et al. A comparison of murine and human immunoproteomes of Helicobacter pylori validates the preclinical murine infection model for antigen screening. Infect Immun 70 11 (2002) 6494-6498
45. Lin Y.F., Wu M., Lin J.T., Sun Y., Chen D., and Chow L. Comparative immunoproteomics of identification and characterization of virulence factors from Helicobacter pylori related to gastric cancer. Mol Cell Proteomics 5 (2006) 1484-1496
46. Sellman B.R., Howell A.P., Kelly-Boyd C., and Baker S.M. Identification of immunogenic and serum binding proteins of Staphylococcus epidermidis. Infect Immun 73 (2005) 6591-6600
47. Portnoi M., Ling E., Feldman G., Dagan R., and Mizrachi-Nebenzahl Y. The vaccine potential of Streptococcus pneumoniae surface lectin- and non-lectin proteins. Vaccine 24 11 (2006) 1868-1873
48. Kaniga K., Compton M.S., Curtiss III R., and Sundaram P. Molecular and functional characterization of Salmonella enterica serovar Typhimurium poxA gene: effect on attenuation of virulence and protection. Infect Immun 66 12 (1998) 5599-5606
49. Rambow-Larsen A.A., and Weiss A.A. Temporal expression of pertussis toxin and Ptl secretion proteins by Bordetella pertussis. J Bacteriol 186 1 (2004) 43-50
50. Harb O.S., and Abu Kwaik Y. Identification of the aspartate-beta-semialdehyde dehydrogenase gene of Legionella pneumophila and characterization of a null mutant. Infect Immun 66 5 (1998) 1898-1903
51. Mahan M.J., Slauch J.M., and Mekalanos J.J. Selection of bacterial virulence genes that are specifically induced in host tissues. Science 259 (1993) 686-768
52. Kwaga J.K., Allan B.J., van der Hurk J.V., Seida H., and Potter A.A. A carAB mutant of avian pathogenic Escherichia coli serogroup O2 is attenuated and effective as a live oral vaccine against colibacillosis in turkeys. Infect Immun 62 9 (1994) 3766-3772
53. Pesci E.C., Milbank J.B., Pearson J.P., McKnight S., Kende A.S., Greenberg E.P., et al. Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 96 20 (1999) 11229-11234
54. Diggle S.P., Lumjiaktase P., Dipilato F., Winzer K., Kunakorn M., Barrett D.A., et al. Functional genetic analysis reveals a 2-alkyl-4-quinolone signaling system in the human pathogen Burkholderia pseudomallei and related bacteria. Chem Biol 13 7 (2006) 701-710
55. Coleman J.P., Hudson L.L., McKnight S.L., Farrow III J.M., Calfee M.W., Lindsey C.A., et al. Pseudomonas aeruginosa PqsA is an anthranilate-coenzyme A ligase. J Bacteriol 190 4 (2008) 1247-1255
56. Hodak H., Wohlkönig A., Smet-Nocca C., Drobecq H., Wieruszeski J.M., Sénéchal M., et al. The peptidyl-prolyl isomerase and chaperone Par27 of Bordetella pertussis as the prototype for a new group of parvulins. J Mol Biol 376 2 (2008) 414-426
57. Cluss R.G., Goel A.S., Rehm H.L., Schoenecker J.G., and Boothby J.T. Coordinate synthesis and turnover of heat shock proteins in Borrelia burgdorferi: degradation of DnaK during recovery from heat shock. Infect Immun 64 5 (1996) 1736-1743
58. de Carvalho A.P., and Pereira E.M. Acellular pertussis vaccine for adolescents. J Pediatr (Rio J) 82 3 (2006) 15-24
59. Leung A.K., Robson W.L., and Davies H.D. Pertussis in adolescents. Adv Ther 24 2 (2007) 353-361
60. Halperin S.A., Smith B., Russell M., Hasselback P., Guasparini R., Skowronski D., et al. An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine 18 14 (2000) 1312-1319
61. Pichichero M.E., Blatter M.M., Kennedy W.A., Hedrick J., Descamps D., and Friedland L.R. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents. Pediatrics 117 4 (2006) 1084-1093
62. Pertussis vaccines-WHO position paper. Weekly Epid Record 80 4 (2005) 31-39